Alexion Pharmaceuticals
Listing Websites about Alexion Pharmaceuticals
Alexion Pharmaceuticals - Wikipedia
(3 days ago) Alexion Pharmaceuticals is an American pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. It became a subsidiary of AstraZeneca in 2021. Its products include eculizumab (Soliris) with $4.064 billion in 2020 revenues and ravulizumab (Ultomiris) with $1.076 billion in 2020 revenues, both used to trea…
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Alexion Pharmaceuticals Company Overview & News
(7 days ago) Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Alexion Pharmaceuticals, Inc. LinkedIn
(7 days ago) Alexion Pharmaceuticals, Inc. 249,266 followers. 1w. Developing medicines takes a village, especially in rare disease. Learn why collaboration with the community, including patients, advocacy
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Alexion Pharmaceuticals Reviews Glassdoor
(5 days ago) Promotions in some departments are infrequent. Uncertainty of changes to benefits, salary, bonus, etc. with AZ acquisition and integration. No fully remote option driving …
Url: Visit Now
Category: Health Detail Drugs
Alexion Pharmaceuticals - Crunchbase Company Profile
(3 days ago) Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Alexion Pharmaceuticals,Inc. Careers and Employment
(5 days ago) Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and delivery of biologic therapeutic products for the treatment …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Alexion Pharmaceuticals U.S. (@AlexionPharmaUS) / Twitter
(5 days ago) Official Twitter feed of Alexion Pharmaceuticals in the U.S. Community guidelines: https://t.co/Ud8NUo6ff2
Url: Visit Now
Category: Pharmaceutical Detail Drugs
Alexion Pharmaceuticals INC -- H1B Data - Salaries, Approvals, LCAs
(3 days ago) What is the H1B Approval Rate for Alexion Pharmaceuticals INC ? Alexion Pharmaceuticals INC filed 8 LCAs in fiscal year 2022, of which 8 were approved and 0 were denied. Also, …
Url: Visit Now
Category: Pharmaceutical Detail Drugs
› Https uhhospitals pay my bill
› Cvs pharmacy dunkirk md hours
› St croix medical center maine
› Https uhhospitals pay my bill
› Taconic pharmacy yorktown heights
› Child care licensing forms texas
› Bradley memorial hospital medical records
› Current trends in healthcare delivery
› Who brought drugs to america
Recently Searched› Galway university hospital address
› Good samaritan medical record
› Interfaith hospital brooklyn medical records
› Health alliance leominster ma
› Behavioral health loma linda ca
› Benson medical supply flint michigan
› Difference medical and health insurance
› Baptist health south florida headquarters
FAQ about Alexion Pharmaceuticals
What does Alexion Pharmaceuticals do?
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).
How many Alexion medicines are approved in the US?
To date, we have five innovative medicines approved for the treatment of seven rare diseases and devastating conditions. Learn more about each of our medicines and the conditions they treat by selecting a product below. Contact Alexion in your region if you are outside of the United States and want to learn about product availability.
How can I learn more about Alexion medicines?
Learn more about each of our medicines and the conditions they treat by selecting a product below. Contact Alexion in your region if you are outside of the United States and want to learn about product availability.
What happened to Alexion antibody technologies?
The company was renamed Alexion Antibody Technologies. In December 2011, Alexion acquired Montreal-based Enobia Pharma, the developer of asfotase alfa, a drug used to treat the genetic disorder hypophosphatasia, for as much as $1.08 billion.